The U.S. Food and Drug Administration (FDA), has recently approved a new continuous glucose monitor (CGM) for diabetes with a sensor that can last for up to six months. The device named ‘Eversense System’ is the world’s first longest-lasting CGM and is expected to be on the market spring of 2022. How will the Eversense E3 system work in your patien
1901 Reached4 Comments1 Likes
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
ACC, AHA and ESC Recommendations for Heart Failure Management
2321 Reached29 Comments2 Likes
Resistant Thyrotoxicosis in Pregnancy
954 Reached4 Comments2 Likes
Pancytopenia, a rare presentation of hyperthyroidism
604 Reached2 Comments